Increased Epstein-Barr virus DNA load and antibodies against EBNA1 and EA in sardinian patients with rheumatoid arthritis

Viral Immunology

Volumn 28, Issue 7, 2015, Pages 385-390

  Erre, Gian Luca ^a   Mameli, Giuseppe ^b   Cossu, Davide ^b   Muzzeddu, Benedetta ^a   Piras, Cristina ^a   Paccagnini, Daniela ^b   Passiu, Giuseppe ^a   Sechi, Leonardo Antonio ^b  

^a UNIVERSITY HOSPITAL OF SASSARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN 1; INTERLEUKIN 6; STEROID; TOCILIZUMAB; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAS28; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; STEROID THERAPY; VIRUS LOAD; AGED; ARTHRITIS, RHEUMATOID; BLOOD; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ITALY;

AGED; ANTIBODIES, VIRAL; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84941002514     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2015.0035     Document Type: Article

References (29)

1. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-2581.
2. Alspaugh MA, Henle G, Lennette ET, and Henle W. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest 1981;67:1134-1140.
3. Alvarez-Lafuente R, Fernández-Gutiérrez B, de Miguel S, et al. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 2005;64:1357-1359.
4. Balandraud N, Guis S, Meynard JB, Auger I, Roudier J, and Roudier C. Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase Epstein-Barr virus load in patients with rheumatoid arthritis. Arthritis Rheum 2007;57:762-767.
5. Balandraud N, Meynard JB, Auger I, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum 2013;48:1223-1228.
6. Catalano MA, Carson DA, Slovin SF, Richman DD, and Vaughan JH. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci U S A 1979; 76:5825-5828.
7. Cocco E, Sardu C, Massa R, et al. Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 2011; 17:182-189.
8. Contu D, Morelli L, Santoni F, Foster JW, Francalacci P, and Cucca F. Y chromosome based evidence for pre-neolithic origin of the genetically homogeneous but diverse Sardinian population: inference for association scans. PLoS One 2008;3:e1430.
9. Cooper GS, Bynum ML, and Somers EC. Recent insight in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering diseases. J Autoimmun 2009;33:197-207.
10. Costenbader KH, and Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther 2006;8:204.
11. Croia C, Serafini B, Bombardieri M, et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis 2013;72:1559-1568.
12. Durandy A, Emilie D, Peuchmaur M, et al. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. J Immunol 1994; 152:5361-5367.
13. Esen BA, Yilmaz G, Uzun S, et al. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. Rheumatol Int 2012; 32:79-83.
14. Haddad E, Paczesny S, Leblond V, et al. Treatment of Blymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial. Blood 2009;97:1590-1597.
15. Kaden J, Petersen S, Kaden K, and May G. Epstein-Barr virus infection after kidney transplantation. Transpl Int 1998;11:S119-S124.
16. Klareskog L, Padyukov J, Ronnelid D, and Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 2006;18:650-655.
17. Mameli G, Cossu D, Cocco E, et al. EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls. J Neuroimmunol 2013;264:120-122.
18. Mameli G, Madeddu G, Mei A, et al. Activation of MSRVtype endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? PLoS One 2013;8:e78474.
19. Mameli G, Poddighe L, Mei A, et al. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One 2012;7:e44991.
20. Mauray S, Fuzzati-Armentero MT, Trouillet P, et al. Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6. Eur J Immunol 2000;30:2065-2073.
21. Miceli-Richard C, Gestermann N, Amiel C, et al. Effect of methotrexate and anti-TNF on Epstein-Barr virus Tcell response and viral load in patients with rheumatoid arthritis or spondylarthropathies. Arthritis Res Ther 2009; 11:R77.
22. Mousavi-Jazi M, Bostrom L, Lovmark C, Linde A, Brytting M, and Sundqvist VA. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol 1998; 25:623-628.
23. Perricone C, Agmon-Levin N, Ceccarelli F, et al. Genetics and autoantibodies. Immunol Res 2013;56:206-219.
24. Ragona G, Sirianni MC, Soddu S, et al. Evidence for disregulation in the control of Epstein-Barr virus latency in patients with AIDS-related complex. Clin Exp Immunol 1986;66:17-24.
25. Sardu C, Cocco E, Mereu A, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One 2012;7:e32487.
26. Tanner JE, and Menezes J. Interleukin-6 and Epstein-Barr virus induction by cyclosporine A. potential role in lymphoproliferative disease. Blood 1994;84:3956-3964.
27. Toussirot E, Wendling D, Tiberghien P, Luka J, and Roudier J. Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 inperipheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis 2000; 59:533-538.
28. Williams H, McAulay K, Macsween KF, et al. The immune response to primary EBV, 2005;129:266-274.
29. Yao QY, Rickinson AB, and Gaston JS, Epstein MA. Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study. Clin Exp Immunol 1986;64:302-310.